MedTrace Logo

Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

NCT00178542 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-05-06

No results posted yet for this study

Summary

The primary objective of this study is to describe characteristics and trends for thrombin generation (TG) and thromboelastography (TEG) at 4 time points during the menstrual cycle.

Conditions

  • Von Willebrand Disease

Sponsors & Collaborators

  • The ZLB Behring Foundation

    collaborator UNKNOWN

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Deborah Brown, MD · The University of Texas Health Science Center, Houston

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178542 on ClinicalTrials.gov